Trial Profile
Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic retinopathy; Neovascular glaucoma
- Focus Therapeutic Use
- 11 Jan 2016 New trial record